Streetbeat News

Stock Prices

CZOO

Trading of Cazoo Group Ltd (CZOO) shares resumed after a temporary halt due to a circuit breaker trigger. The halt was implemented to manage volatility in the stock's price.

Portfolio Pulse from Happy Mohamed

March 21, 2024 | 1:43 pm

SPY

The Federal Reserve's dovish stance, as revealed in the March meeting, has led to a market rally, with the SPDR S&P 500 ETF Trust (SPY) reaching new heights. Ed Yardeni highlighted the Fed's decision to maintain its projection for three 25 basis point reductions in the federal funds rate within the year, despite improved GDP growth and inflation forecasts. Fed Chair Powell's confirmation of a dovish position and readiness to lower rates if inflation continues to decrease has fueled optimism, pushing the S&P 500 closer to Yardeni's year-end target of 5,400. However, Yardeni warns of potential risks due to overwhelmingly positive market sentiment.

Portfolio Pulse from Piero Cingari

March 21, 2024 | 1:42 pm

BTCUSD

ETHUSD

Bitcoin and Ethereum saw significant gains, with Bitcoin surpassing the $67,000 mark and Ethereum trading above $3,500, following the Fed's decision to keep interest rates unchanged. Ondo emerged as the top gainer with a 31.6% increase, while Render experienced the largest loss. The global crypto market cap increased by 5.5% to $2.55 trillion.

Portfolio Pulse from Avi Kapoor

March 21, 2024 | 1:41 pm

AXL

Traders are closely watching American Axle & Manufacturing (AXL) as shares experience increased volume following a blog post suggesting that the company is a target for acquisition.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:37 pm

FIVE

MU

SMH

SPY

Semiconductor stocks, including the ETF SMH, gained following positive developments from Micron (MU). Five Below (FIVE) experienced a decline after its earnings report. Overall, stock indexes, represented by SPY, increased after the Federal Reserve's decision.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:37 pm

BNOX

Bionomics Limited (NASDAQ:BNOX) released detailed data from its Phase 2b ATTUNE trial of BNC210 for PTSD, showing significant improvements in primary and several secondary endpoints. The trial demonstrated BNC210's efficacy in reducing PTSD symptoms, depressive symptoms, and improving sleep, with a favorable safety profile. Bionomics plans to discuss these results with the FDA in Q2 2024 and proceed to a late-stage trial in Q4 2024. Following the news, BNOX shares experienced volatility, dropping 1.09% to $1.03 after initially spiking to $1.30 in premarket trading.

Portfolio Pulse from Vandana Singh

March 21, 2024 | 1:36 pm

SWKH

SWK Holdings (NASDAQ:SWKH) reported Q4 earnings with an EPS of $0.23, missing estimates by -23.0% against an expected $0.3. Revenue increased by $93 thousand year-over-year. Previously, the company had beaten EPS estimates in Q3 2023, which led to a 1.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 1:35 pm

KRON

Kronos Bio (NASDAQ:KRON) reported Q4 earnings with an EPS of $-0.43, beating estimates by 17.0% against an expected $-0.52. Revenue increased by $2.29 million from the previous year. Despite beating estimates this quarter, a miss in the last quarter led to a 1.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 1:35 pm

DIS

A group of current and former public company directors have sent a letter to The Walt Disney Company's Board of Directors in support of Nelson Peltz and Trian, detailing their positive experiences and the value they added to companies like H.J. Heinz and Procter & Gamble. They encourage Disney to collaborate with Peltz and Trian to enhance shareholder value.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:33 pm

COIN

Coinbase shares are trading higher amid a rise in Bitcoin, indicating a positive correlation between the company's stock performance and the cryptocurrency market.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 1:32 pm